JEFFREY L. WOLF, M.D.; STEPHEN J. FORMAN, M.D.; LAIMA GAIDULIS, M.S.; KARL G. BLUME, M.D.
This content is PDF only. Please click on the PDF icon to access.
To the editor: In their article on serum angiotensin-converting enzyme in diabetes mellitus, Lieberman and Sastre (1) state that the enzyme levels are not elevated in Hodgkin's disease. They refer to their work in which only one of 24 patients studied had elevated levels (2). Rømer (3) has also looked at angiotensin-converting enzyme levels in Hodgkin's disease and reports only one of 23 patients positive. Because there is no indication in either paper of the patients' disease status and treatment history and because of our own interest in identifying serum markers of malignancy, we have prospectively looked at serum angiotensin-converting
WOLF JL, FORMAN SJ, GAIDULIS L, et al. Angiotensin-Converting Enzyme in Untreated Hodgkin's Disease. Ann Intern Med. 1981;94:545. doi: https://doi.org/10.7326/0003-4819-94-4-545_2
Download citation file:
Published: Ann Intern Med. 1981;94(4_Part_1):545.
Copyright © 2020 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use